Trial Profile
Safety and efficacy trial of caspofungin versus fluconazole for the treatment of invasive fungal infection in high-risk liver transplant patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2016
Price :
$35
*
At a glance
- Drugs Caspofungin (Primary) ; Fluconazole
- Indications Mycoses
- Focus Therapeutic Use
- 04 Jan 2016 New trial record
- 28 Dec 2015 Results published in the Liver Transplantation